Daily Stock Setups

/ CORRECTION - Trinity Biotech plc to Announce Second Quarter 2009 Financial Results on July 23, 2009

Posted on: Mon, 13 Jul 2009 07:58:00 EDT

Symbols: TRIB

Do you know when to trade TRIB ?

Check for a PowerRating from TradingMarkets

DUBLIN, IRELAND, Jul 13, 2009 (MARKETWIRE via COMTEX) --
TRIB | Quote | Chart | News | PowerRating -- In the news release, "Trinity Biotech plc to Announce Second Quarter
2009 Financial Results on July 23, 2009" issued earlier today by
Trinity Biotech (NASDAQ: TRIB), we are advised by the company that
the date in the subheadline should read "July 23" rather than "July
13" as originally issued. Complete corrected text follows.

Trinity Biotech plc to Announce Second Quarter 2009 Financial Results
on July 23, 2009

Conference Call Scheduled for July 23, 2009 at 11:00 am EASTERN

DUBLIN, IRELAND -- July 13, 2009 -- Trinity Biotech plc (NASDAQ:
TRIB), a leading developer and manufacturer of diagnostic products
for the point-of-care and clinical laboratory markets, will report
financial results for the second quarter of 2009 on Thursday, July 23,
2009. The Company has scheduled a conference call for that same day,
Thursday, July 23, 2009, at 11:00am ET (4:00pm BST) to discuss the
results of the quarter.

Interested parties can access the call by dialing:


     USA:           1-800-860-2442
     International: 1-412-858-4600

A simultaneous webcast of the call can be accessed at:
http://www.videonewswire.com/event.asp?id=60389

A replay of the call can be accessed until July 27, 2009 by dialing:


     USA:                1-877-344-7529
     International:      1-412-317-0088
     Conference ID #:    432266

The webcast of the call will be available for 30 days at:
http://www.videonewswire.com/event.asp?id=60389

About Trinity Biotech plc

Headquartered in Wicklow, Ireland, Trinity Biotech develops, acquires
manufactures and markets over 500 diagnostic products for the
point-of-care and clinical laboratory segments of the diagnostic
market. The broad line of test kits are used to detect infectious
diseases, sexually transmitted diseases, blood coagulation disorders,
and autoimmune diseases. Trinity Biotech sells worldwide in over 80
countries through its own sales force and a network of international
distributors and strategic partners.

For further information please see the company's website:
http://www.trinitybiotech.com.


Contact:
Mr. Kevin Tansley
Chief Financial Officer
Trinity Biotech plc
353-1-2769800

Joe Diaz, Joe Dorame and Robert Blum
Lytham Partners, LLC
602-889-9700

SOURCE: Trinity Biotech

For full details on Trinity Biotech plc ADR (TRIB) TRIB. Trinity Biotech plc ADR (TRIB) has Short Term PowerRatings at TradingMarkets. Details on Trinity Biotech plc ADR (TRIB) Short Term PowerRatings is available at This Link.

More News: Market Updates | Stock Alerts | All Trading News

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.